Preclinical Evaluation of [<sup>68</sup>Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors.

Cells · 2018 · PMC6162391 · PMID 30231504

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Saturation of EGFR in A431 xenografts resulted in highly significant ( p < 0.001) reduction in the [ 68 Ga]Ga-DFO-ZEGFR:2377 uptake in tumors ( Figure 6 and Figure 9 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.